Cargando…
miR-4443 promotes radiation resistance of esophageal squamous cell carcinoma via targeting PTPRJ
BACKGROUND: Radiotherapy is one of the main treatments for esophageal squamous cell carcinoma (ESCC), but its efficacy is limited by radioresistance. MicroRNAs play a crucial role in posttranscriptional regulation, which is linked to the cancer response to radiation. METHODS: We successfully establi...
Autores principales: | Shi, Xiaobo, Liu, Xiaoxiao, Huang, Shan, Hao, Yu, Pan, Shupei, Ke, Yue, Guo, Wei, Wang, Yuchen, Ma, Hongbing |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9795664/ https://www.ncbi.nlm.nih.gov/pubmed/36578050 http://dx.doi.org/10.1186/s12967-022-03818-5 |
Ejemplares similares
-
Aberrant expression of microRNA-4443 (miR-4443) in human diseases
por: Mao, Yunan, et al.
Publicado: (2022) -
miR-4443 Participates in the Malignancy of Breast Cancer
por: Chen, Xiu, et al.
Publicado: (2016) -
miR-17-5p and miR-4443 Promote Esophageal Squamous Cell Carcinoma Development by Targeting TIMP2
por: Wang, Xiaojun, et al.
Publicado: (2021) -
Identification and validation of an autophagy-related gene signature for predicting prognosis in patients with esophageal squamous cell carcinoma
por: Shi, Xiaobo, et al.
Publicado: (2022) -
A Novel Autophagy-Related Long Non-Coding RNA Signature to Predict Prognosis and Therapeutic Response in Esophageal Squamous Cell Carcinoma
por: Shi, Xiaobo, et al.
Publicado: (2021)